Richard Kim, M.D., former professor of Medicine and clinical pharmacologist at Vanderbilt University, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology at 8 a.m. Thursday, Feb. 27, in 208 Light Hall.
Kim, professor and chair of the Division of Clinical Pharmacology at the University of Western Ontario in London, Ontario, Canada, will discuss “Translating Mechanisms of Drug Disposition and Response to Personalized Medicine.”
Kim earned his medical degree from the University of Saskatchewan in 1987. After completing an internship and residency training in internal medicine, he came to Vanderbilt in 1991 for three years of postdoctoral fellowship training in Clinical Pharmacology.
He joined the Vanderbilt faculty in 1994 and was named full professor a decade later. In 2006, he moved to the University of Western Ontario to lead a research program in translational and personalized medicine.
In 2012, Kim was awarded the Wolfe Medical Research Chair in Pharmacogenomics by the Schulich School of Medicine and Dentistry at Western. He also directs the Centre for Clinical Investigation and Therapeutics at University Hospital in London.
A fellow of the Royal College of Physicians of Canada, the American College of Physicians, the American Association of Pharmaceutical Scientists and the Canadian Academy of Health Sciences, Kim also is an elected member of the American Society for Clinical Investigation.
The lecture, named for the late Grant R. Wilkinson, Ph.D., D.Sc., a distinguished Vanderbilt clinical pharmacologist, is sponsored by Vanderbilt’s Division of Clinical Pharmacology and the Department of Pharmacology.
